Veradigm | MDRX - Ebit


Veradigm reported $-45.47M in EBIT for its fiscal quarter ending in December of 2022.





Ebit Change Date
Alcidion AUD 2.2M 1.76M Dec/2025
Ambu A/S DKK 293M 72M Sep/2026
Amplifon EUR 40.48M 39.38M Sep/2026
Cardinal Health USD 819M 5M Sep/2026
Centene USD -45.41B 2.24B Sep/2026
Charles River Laboratories USD 221.85M 101.96M Sep/2026
Cigna USD 2.4B 217M Sep/2026
Coloplast 1.85B 102M Dec/2025
Convatec Group USD 262.5M 39.7M Dec/2024
CVS Health USD 3.57B 3.16B Sep/2026
Diasorin EUR 69.05M 13.05M Jun/2026
Elevance Health USD 2.15B 149M Sep/2026
General Electric Aerospace USD 2.22B 123M Sep/2026
Gulf Medical Proj AED 25.67M 5.13M Mar/2026
Humana USD 1.36B 394M Jun/2026
IQVIA Holdings USD 608M 1.99B Sep/2026
Laboratory Of America USD 418M 38.7M Sep/2026
Max Healthcare Institute Limited 5.74B 1.07B Sep/2026
Maximus USD 161.43M 12.94M Jun/2026
McKesson USD 1.69B 266M Sep/2026
Med Life RON 43.11M 3.02M Mar/2026
Molina Healthcare USD 106M 51M Sep/2026
Omnicell USD 14.93M 21.39M Sep/2026
Oriola-kd EUR 6.5M 2.1M Sep/2026
Owens Minor USD 814K 28.08M Dec/2025
Quest Diagnostics USD 479M 20M Sep/2026
Rede D'or Sao Luiz BRL 21.63B 18.63B Sep/2026
Siemens Healthineers EUR 847M 100M Sep/2026
Sonova Holding CHF 296.8M 156.9M Dec/2025
Supermax Corporation Bhd MYR 36.86M 74.71M Jun/2026
UnitedHealth USD 6.34B 1.65B Sep/2026
Veeva Systems USD 275.02M 1.91M Jun/2026
Veradigm USD -45.47M 70.47M Dec/2022
Xerox USD 30M 8M Jun/2025